Quantitative Analysis of BRCA1 and BRCA2 Germline Splicing Variants Using a Novel RNA-Massively Parallel Sequencing Assay

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2018.00286
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Novel Applications of Massively Parallel Sequencing (MPS) in Forensic Analysis

Electrophoresis
BiochemistryClinical BiochemistryAnalytical Chemistry
2018English

Novel Germline Mutations and Unclassified Variants of BRCA1 and BRCA2 Genes in Chinese Women With Familial Breast/Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

The Germline Mutational Landscape of BRCA1 and BRCA2 in Brazil

Scientific Reports
Multidisciplinary
2018English

Analysis of the Pathogenic Variants of BRCA1 and BRCA2 Using Next-Generation Sequencing in Women With Familial Breast Cancer: A Case–control Study

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Massively Parallel Sequencing of Human Urinary Exosome/Microvesicle RNA Reveals a Predominance of Non-Coding RNA

PLoS ONE
Multidisciplinary
2014English

Splicing and Multifactorial Analysis of Intronic BRCA1 and BRCA2 Sequence Variants Identifies Clinically Significant Splicing Aberrations Up to 12 Nucleotides From the Intron/Exon Boundary

Human Mutation
Genetics
2011English

Massively Parallel, Time-Resolved Single-Cell RNA Sequencing With scNT-Seq

2019English

Testing the Regulatory Consequences of 1,049 Schizophrenia Associated Variants With a Massively Parallel Reporter Assay

2018English

Germline BRCA1 and BRCA2 Deleterious Mutations and Variants of Unknown Clinical Significance Associated With Breast/Ovarian Cancer: A Report From North India

Cancer Management and Research
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy